Clinical trial
A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor…
NCT00205231 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00205231 |
|---|---|
| Title | A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease |
| Official title | A Pilot Study to Examine the Feasibility and Effect on Tumor Necrosis Factor (TNF) Inhibition on HIV Disease |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | Immunex Corporation Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | etanercept |
| Enrollment | 25 |
| Start date | May 1, 2002 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 22, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: